BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gobran ST, Ancuta P, Shoukry NH. A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection. Front Immunol 2021;12:726419. [PMID: 34456931 DOI: 10.3389/fimmu.2021.726419] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Sepúlveda-Crespo D, Treviño-Nakoura A, Bellon JM, Jiménez-Sousa MA, Ryan P, Martínez I, Fernández-Rodríguez A, Resino S. Diagnostic Performance of the HCV Core Antigen Test To Identify Hepatitis C in HIV-Infected Patients: a Systematic Review and Meta-Analysis. J Clin Microbiol 2023;61:e0133122. [PMID: 36537787 DOI: 10.1128/jcm.01331-22] [Reference Citation Analysis]
2 von Csefalvay C. Agent-based modeling. Computational Modeling of Infectious Disease 2023. [DOI: 10.1016/b978-0-32-395389-4.00018-9] [Reference Citation Analysis]
3 References. Computational Modeling of Infectious Disease 2023. [DOI: 10.1016/b978-0-32-395389-4.00020-7] [Reference Citation Analysis]
4 Munyuza C, Ji H, Lee ER. Probe Capture Enrichment Methods for HIV and HCV Genome Sequencing and Drug Resistance Genotyping. Pathogens 2022;11:693. [PMID: 35745547 DOI: 10.3390/pathogens11060693] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chen F, Tang H, Han J, Li D, Li P, Wang N, Han M, Wang L, Wang L. Association of HCV Prior Infection and Unprotected Sex on Subsequent HIV Acquisition Risk in the Era of Treatment as Prevention. Front Med (Lausanne) 2022;9:902271. [PMID: 35685415 DOI: 10.3389/fmed.2022.902271] [Reference Citation Analysis]
6 Martinez MA, Tural C, Franco S. Circulating MicroRNAs as a Tool for Diagnosis of Liver Disease Progression in People Living with HIV-1. Viruses 2022;14:1118. [DOI: 10.3390/v14061118] [Reference Citation Analysis]
7 Dalla E, Bulfoni M, Cesselli D, Pravisani R, Hidaka M, Eguchi S, Baccarani U. Reinfection of Transplanted Livers in HCV- and HCV/HIV-Infected Patients Is Characterized by a Different MicroRNA Expression Profile. Cells 2022;11:690. [DOI: 10.3390/cells11040690] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 El Kassas M, Eltabbakh M, Elbadry M, Tawheed A, Elbaz T. Establishing a research production line in real-life settings: the case of Hepatitis C management in a viral hepatitis specialized Egyptian center. Curr Med Res Opin 2022;:1-23. [PMID: 35118916 DOI: 10.1080/03007995.2022.2038489] [Reference Citation Analysis]
9 Marino A, Zafarana G, Ceccarelli M, Cosentino F, Moscatt V, Bruno G, Bruno R, Benanti F, Cacopardo B, Celesia BM. Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience. Diagnostics (Basel) 2021;11:2336. [PMID: 34943573 DOI: 10.3390/diagnostics11122336] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]